$188M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST Spdr Series Trust | 570,000 | +100.1% | $90M | 48.0% |
| 2 | ISHARES TR Ishares Tr | 700,000 | +0.0% | $70M | 37.5% |
| 3 | RPRX Royalty Pharma Plc | 11,000 | +0.0% | $616,770 | 0.3% |
| 4 | NRIX Nurix Therapeutics Inc | 25,000 | −12.9% | $606,500 | 0.3% |
| 5 | INCY Incyte Corp | 5,300 | +0.0% | $600,808 | 0.3% |
| 6 | ARGX Argenx Se | 641 | +0.0% | $594,701 | 0.3% |
| 7 | IRON Disc Medicine Inc | 8,000 | +0.0% | $585,120 | 0.3% |
| 8 | RAPP Rapport Therapeutics Inc | 14,000 | +0.0% | $583,380 | 0.3% |
| 9 | RARE Ultragenyx Pharmaceutical In | 17,000 | −23.1% | $567,630 | 0.3% |
| 10 | TRVI Trevi Therapeutics Inc | 30,000 | +0.0% | $559,500 | 0.3% |
| 11 | GLUE Monte Rosa Therapeutics Inc | 23,000 | −17.9% | $556,600 | 0.3% |
| 12 | TGTX Tg Therapeutics Inc | 10,000 | −23.1% | $549,400 | 0.3% |
| 13 | HALO Halozyme Therapeutics Inc | 7,000 | −12.8% | $547,890 | 0.3% |
| 14 | IONS Ionis Pharmaceuticals Inc | 6,800 | +0.0% | $539,172 | 0.3% |
| 15 | PHVS Pharvaris N V | 15,000 | −25.0% | $518,700 | 0.3% |
| 16 | ARQT Arcutis Biotherapeutics Inc | 19,700 | +0.0% | $516,534 | 0.3% |
| 17 | AUPH Aurinia Pharmaceuticals Inc | 30,000 | +0.0% | $509,100 | 0.3% |
| 18 | NBIX Neurocrine Biosciences Inc | 3,000 | −22.0% | $505,605 | 0.3% |
| 19 | IMVT Immunovant Inc | 13,000 | −32.3% | $500,890 | 0.3% |
| 20 | ACAD Acadia Pharmaceuticals Inc | 19,766 | +0.0% | $500,080 | 0.3% |
| 21 | PTCT Ptc Therapeutics Inc | 6,000 | +0.0% | $489,420 | 0.3% |
| 22 | CLDX Celldex Therapeutics Inc New | 13,000 | +0.0% | $483,730 | 0.3% |
| 23 | IMCR Immunocore Hldgs Plc | 15,141 | +0.0% | $480,727 | 0.3% |
| 24 | DFTX Definium Therapeutics Inc | 10,000 | −71.3% | $470,400 | 0.3% |
| 25 | COGT Cogent Biosciences Inc | 12,000 | +0.0% | $464,400 | 0.2% |
| 26 | KYMR Kymera Therapeutics Inc | 4,000 | −36.5% | $458,680 | 0.2% |
| 27 | DYN Dyne Therapeutics Inc | 20,000 | +0.0% | $444,200 | 0.2% |
| 28 | ALNY Alnylam Pharmaceuticals Inc | 1,465 | +0.0% | $441,009 | 0.2% |
| 29 | TARS Tarsus Pharmaceuticals Inc | 7,000 | +0.0% | $440,580 | 0.2% |
| 30 | SNDX Syndax Pharmaceuticals Inc | 20,000 | +0.0% | $437,200 | 0.2% |
| 31 | EXEL Exelixis Inc | 8,000 | −33.0% | $435,280 | 0.2% |
| 32 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 11,000 | +0.0% | $411,620 | 0.2% |
| 33 | NAMS Newamsterdam Pharma Company | 12,000 | −20.0% | $406,680 | 0.2% |
| 34 | ASND Ascendis Pharma A/S | 1,500 | — | $400,080 | 0.2% |
| 35 | LQDA Liquidia Corporation | 5,000 | — | $398,650 | 0.2% |
| 36 | STOK Stoke Therapeutics Inc | 12,000 | +0.0% | $392,640 | 0.2% |
| 37 | VKTX Viking Therapeutics Inc | 10,000 | −33.3% | $390,100 | 0.2% |
| 38 | IMNM Immunome Inc | 18,000 | −10.0% | $381,420 | 0.2% |
| 39 | PTGX Protagonist Therapeutics Inc | 3,000 | +0.0% | $367,740 | 0.2% |
| 40 | HRMY Harmony Biosciences Hldgs In | 10,000 | −30.0% | $364,100 | 0.2% |
| 41 | ELVN Enliven Therapeutics Inc | 7,000 | +0.0% | $355,250 | 0.2% |
| 42 | SYRE Spyre Therapeutics Inc | 4,000 | −22.5% | $355,120 | 0.2% |
| 43 | NTLA Intellia Therapeutics Inc | 20,000 | −25.7% | $338,400 | 0.2% |
| 44 | MDGL Madrigal Pharmaceuticals Inc | 600 | +0.0% | $322,170 | 0.2% |
| 45 | KNSA Kiniksa Pharmaceuticals Intl | 5,000 | −44.4% | $319,750 | 0.2% |
| 46 | ALKS Alkermes Plc | 6,000 | +0.0% | $314,370 | 0.2% |
| 47 | TNGX Tango Therapeutics Inc | 10,000 | −30.6% | $312,600 | 0.2% |
| 48 | ARDX Ardelyx Inc | 60,000 | −25.0% | $306,000 | 0.2% |
| 49 | VERA Vera Therapeutics Inc | 7,000 | −30.0% | $300,370 | 0.2% |
| 50 | MIRM Mirum Pharmaceuticals Inc | 2,500 | −50.0% | $292,675 | 0.2% |